<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bénédicte Callens</style></author><author><style face="normal" font="default" size="100%">Haesebrouck,F.</style></author><author><style face="normal" font="default" size="100%">Dewulf,J.</style></author><author><style face="normal" font="default" size="100%">Boyen,F.</style></author><author><style face="normal" font="default" size="100%">Butaye,P.</style></author><author><style face="normal" font="default" size="100%">Boudewijn Catry</style></author><author><style face="normal" font="default" size="100%">P Wattiau</style></author><author><style face="normal" font="default" size="100%">E. De Graef</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Risico op colistineresistentie neemt toe</style></title><secondary-title><style face="normal" font="default" size="100%">Vlaams Diergeneeskundig Tijdschrift</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">colistine</style></keyword><keyword><style  face="normal" font="default" size="100%">resistentie</style></keyword><keyword><style  face="normal" font="default" size="100%">risico</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2016</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">40</style></number><volume><style face="normal" font="default" size="100%">85</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;In a recent article from China, a transferable resistance mechanism has been described in Escherichia&lt;br /&gt;
coli (E. coli), isolated from food-producing animals, meat and hospital patients (Liu et al., 2015).&lt;br /&gt;
Recently, this resistance mechanism has also been found in Denmark, France, the United Kingdom and&lt;br /&gt;
Belgium. Colistin is considered as one of the last resort treatments against multi-resistant bacteria in&lt;br /&gt;
human medicine, especially for patients with cystic fibrosis. Alertness is needed and the new resistance&lt;br /&gt;
mechanism has to be detected properly in animal and human related bacteria.&lt;/p&gt;
</style></abstract><section><style face="normal" font="default" size="100%">36</style></section></record></records></xml>